5AM Venture Management, LLC
data from 30/09/2025
Capitalization
$ 273.045 M
4.97 %
Performance
$ -2.534 B
-521.85 %
| Date | Ticket | Name | Weight | Capitalization | Share number | First added | Performance ($) | Performance (%) |
|---|---|---|---|---|---|---|---|---|
| 2025/09/30 | SKYE | SKYE BIOSCIENCE INC | 13.94% | 38.049 M $ | 9681763 | 2024/06/30 | -2.478 M $ | -5.98 % |
| 2025/09/30 | TRDA | ENTRADA THERAPEUTICS INC | 9.04% | 24.687 M $ | 4256379 | 2021/12/31 | -3.964 M $ | -13.69 % |
| 2025/09/30 | PHVS | PHARVARIS N V | 7.29% | 19.900 M $ | 797600 | 2022/06/30 | 5.862 M $ | 41.76 % |
| 2025/09/30 | CAMP | CAMP4 THERAPEUTICS CORP | 6.45% | 17.607 M $ | 5869091 | 2024/12/31 | 4.538 M $ | 106.90 % |
| 2025/09/30 | CNTA | CENTESSA PHARMACEUTICALS PLC | 6.05% | 16.513 M $ | 680945 | 2024/03/31 | 9.232 M $ | 84.55 % |
| 2025/09/30 | VRDN | VIRIDIAN THERAPEUTICS INC | 5.82% | 15.896 M $ | 736595 | 2022/09/30 | 5.598 M $ | 54.36 % |
| 2025/09/30 | ELVN | ENLIVEN THERAPEUTICS INC | 5.79% | 15.813 M $ | 772477 | 2023/03/31 | 316.715 K $ | 2.04 % |
| 2025/09/30 | EYPT | EYEPOINT PHARMACEUTICALS INC | 5.48% | 14.952 M $ | 1050000 | 2024/06/30 | 5.072 M $ | 51.33 % |
| 2025/09/30 | DNTH | DIANTHUS THERAPEUTICS INC | 5.26% | 14.365 M $ | 365053 | 2023/09/30 | 20.404 M $ | 111.22 % |
| 2025/09/30 | TYRA | TYRA BIOSCIENCES INC | 4.81% | 13.141 M $ | 939298 | 2023/09/30 | 4.152 M $ | 46.19 % |
| 2025/09/30 | CLDX | CELLDEX THERAPEUTICS INC NEW | 4.71% | 12.864 M $ | 497270 | 2023/06/30 | 2.745 M $ | 27.13 % |
| 2025/09/30 | ERAS | ERASCA INC | 4.32% | 11.784 M $ | 5405404 | 2024/06/30 | 4.919 M $ | 71.65 % |
| 2025/09/30 | PRAX | PRAXIS PRECISION MEDICINES I | 3.30% | 9.010 M $ | 170000 | 2024/03/31 | 1.862 M $ | 26.04 % |
| 2025/09/30 | GHRS | GH RESEARCH PLC | 3.00% | 8.189 M $ | 572665 | 2023/06/30 | 1.208 M $ | 17.31 % |
| 2025/09/30 | TECX | TECTONIC THERAPEUTIC INC | 2.94% | 8.028 M $ | 511660 | 2024/06/30 | -2.139 M $ | -21.04 % |
| 2025/09/30 | BHVN | BIOHAVEN LTD | 2.63% | 7.189 M $ | 478972 | 2023/12/31 | 431.074 K $ | 6.38 % |
| 2025/09/30 | ARTV | ARTIVA BIOTHERAPEUTICS INC | 2.47% | 6.754 M $ | 2353304 | 2024/09/30 | 3.200 M $ | 90.07 % |
| 2025/09/30 | SRZN | SURROZEN INC | 1.46% | 3.994 M $ | 310000 | 2025/03/31 | 1.225 M $ | 44.18 % |
| 2025/09/30 | TARA | PROTARA THERAPEUTICS INC | 1.27% | 3.480 M $ | 800000 | 2024/12/31 | 1.056 M $ | 43.56 % |
| 2025/09/30 | ALEC | ALECTOR INC | 1.08% | 2.948 M $ | 995841 | 2024/12/31 | 1.554 M $ | 111.43 % |
| 2025/09/30 | SLN | SILENCE THERAPEUTICS PLC | 0.91% | 2.471 M $ | 476200 | 2024/03/31 | -290.481 K $ | -10.52 % |
| 2025/09/30 | ADVM | ADVERUM BIOTECHNOLOGIES INC | 0.90% | 2.454 M $ | 541666 | 2024/03/31 | 1.289 M $ | 110.70 % |
| 2025/09/30 | RLYB | RALLYBIO CORP | 0.66% | 1.812 M $ | 3630724 | 2021/09/30 | 584.546 K $ | 47.63 % |
| 2025/09/30 | ZNTL | ZENTALIS PHARMACEUTICALS INC | 0.27% | 739.900 K $ | 490000 | 2023/06/30 | 171.500 K $ | 30.17 % |
| 2025/09/30 | MRSN | MERSANA THERAPEUTICS INC | 0.15% | 405.072 K $ | 52200 | 2025/09/30 | 0.000 $ | 0.00 % |
| 2025/09/30 | SCPH | SCPHARMACEUTICALS INC | 0.00% | 0.000 $ | 0 | 2019/12/31 | 0.000 $ | 0.00 % |
| 2025/09/30 | VOR | VOR BIOPHARMA INC | 0.00% | 0.000 $ | 0 | 2021/03/31 | 0.000 $ | 0.00 % |
| 2025/09/30 | MRSN | MERSANA THERAPEUTICS INC | 0.00% | 0.000 $ | 0 | 2023/03/31 | 0.000 $ | 0.00 % |
| 2025/09/30 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 0.00% | 0.000 $ | 0 | 2023/03/31 | 0.000 $ | 0.00 % |
| 2025/09/30 | VKTX | VIKING THERAPEUTICS INC | 0.00% | 0.000 $ | 0 | 2023/03/31 | 0.000 $ | 0.00 % |